AskBorsa

SPINALEX results, Fiscal year 2023

Net profit, assets, equity and cash flow for Fiscal year 2023, against the same period a year earlier, from the published financial statements. fiscal year starts in July.

Net profit89.86 millionEGP · +156.7% vs the same period a year earlier
Total assets893 millionEGP · +29.9% vs the same period a year earlier
Shareholders' equity689 millionEGP · +15.0% vs the same period a year earlier
Operating cash flow-11.49 millionEGP · +71.8% vs the same period a year earlier

In short

  • SPINALEX's net profit for Fiscal year 2023 was about 89.86 million EGP, up +156.7% from 35 million EGP in Fiscal year 2022.
  • Total assets at the end of Fiscal year 2023 were about 893 million EGP, and shareholders' equity about 689 million EGP.
  • Operating cash flow for Fiscal year 2023 was negative at 11.49 million EGP.
Source: the Fiscal year 2023 financial statements

Key lines against the same period a year earlier

This periodFiscal year 2022Change
Net profit89.86 million35 million+156.7%
Gross profit85.99 million55.61 million+54.6%
Total assets893 million688 million+29.9%
Total liabilities204 million88.7 million+130.3%
Shareholders' equity689 million599 million+15.0%
Total liabilities and equity893 million688 million+29.9%
Operating cash flow-11.49 million-40.68 million+71.8%
Investing cash flow56.89 million39.04 million+45.7%
Financing cash flow26.86 million-8.86 million+403.0%
Net change in cash72.27 million-10.51 million+787.7%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.

Official report (PDF)All of SPINALEX's statements, five yearsAsk the AI analyst about SPIN

SPINALEX's Fiscal year 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for SPINALEX